JFD01307SC is primarily utilized in the field of pharmaceutical research as a potential therapeutic agent. Its application is focused on targeting specific biological pathways, making it a candidate for the treatment of certain diseases, particularly those involving abnormal cell proliferation. Researchers are exploring its efficacy in preclinical studies to determine its potential in inhibiting key enzymes or proteins involved in disease progression. Additionally, it is being investigated for its role in combination therapies, where it may enhance the effectiveness of existing treatments. Its use is currently limited to laboratory settings, with ongoing studies aimed at understanding its safety, pharmacokinetics, and therapeutic potential.